InvestSMART

Sonic Healthcare Limited (ASX:SHL)

ALERT: Price-sensitive ASX Announcement for SHL
Current share price for SHL : $19.350 -4.21 (-17.87%)+
Announcement
Release
20 Aug 2026 9:22AM
Price at Release
$23.560
Full Release
download
Summary
Sonic Healthcare Limited reported a robust financial performance for the fiscal year ending 30 June 2026, achieving significant growth in revenue and profits. The company posted a 13% increase in revenue, reaching A$10,867 million, and a 17% rise in underlying net profit to A$621 million. The results were driven by strong organic growth, synergies from acquisitions, and disciplined capital management. Sonic Healthcare also continued to focus on digital transformation and AI initiatives, while maintaining a progressive dividend policy. The company operates in nine countries, providing medical diagnostics services to over 140 million patients annually.
Key Points
  • Revenue growth of 13% with strong organic growth of 5%.
  • EBITDA increased by 11%, with earnings per share rising 14%.
  • Successful acquisition and integration of LADR Laboratory Group.
  • Synergy realization from acquisitions in Germany and Switzerland.
  • Initiatives in digital and AI transformation launched.
  • Progressive dividend increased by 1 cent to $1.08 per share.
  • Sonic Healthcare operates in nine countries serving 140 million patients.
  • Strong focus on operational excellence and medical leadership.
  • Disciplined capital management with sale and leaseback of Brisbane lab.
  • First nine months as CEO for Dr. Jim Newcombe who emphasized growth and value creation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.